The present invention is directed to anti-CD79b antibody, huMA79b.v28, and compositions of matter thereof useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.

Edits on 20 Sep, 2023

"Add patent inventor(s)"

Golden AI

edited on 20 Sep, 2023

Edits made to:

Infobox (+7 properties)

Infobox

Patent Inventor Names

Andrew Polson0

Bing Zheng0

David Dornan0

Jagath Reddy Junutula0

Kristi Elkins0

Mark Dennis0

Yvonne Chen0

Edits on 5 Jul, 2023

"update inverses"

Golden AI

edited on 5 Jul, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11692041 Antibody molecules which bind CD45

Edits on 25 May, 2023

"Remove leading 0 from patent number"

Golden AI

edited on 25 May, 2023

Edits made to:

Infobox (+1/-1 properties)

‌

US Patent 08088378 Anti-CD79B antibodies and immunoconjugates and methods of use US Patent 8088378 Anti-CD79B antibodies and immunoconjugates and methods of use

Infobox

Patent Number

08088378

Patent Number

8088378

Edits on 14 Dec, 2021

"Created via: Entity Importer"

Golden AI

created this topic on 14 Dec, 2021

Edits made to:

Infobox (+7 properties)

‌

US Patent 08088378 Anti-CD79B antibodies and immunoconjugates and methods of use

Infobox

Is a

Patent

Patent jurisdiction

United States Patent and Trademark Office

Patent number

08088378

Date of patent

January 3, 2012

Patent application number

12173465

Date Filed

July 15, 2008

Patent primary examiner

‌

Ronald Schwadron

Find more entities like US Patent 8088378 Anti-CD79B antibodies and immunoconjugates and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.